Supported metal catalysts play a significant role in the selective organic synthesis and valorization of bio-derived platform molecules, and the development of catalyst preparation method is an important research topic. The facile in situ reduction synthesis strategy was investigated to prepare gold catalysts on Ti3AlC2-derived nanofibrous materials, using “as-produced H2” during hydrothermal synthesis as a reductive agent. The results of catalyst characterizations revealed that the metallic Au NPs (gold nanoparticles) were loaded with high efficiency. The new series of Aupre/Ti3AlxC2Ty catalysts as prepared by the in situ reduction method generally exhibited higher conversions in the selective oxidation of biomass-derived HMF (5-hydroxymethylfurfural) and aromatic alcohols, outperforming the traditional series of Audp/Ti3AlxC2Ty catalysts as made by the deposition–precipitation method. The HMF conversion was 96.9% over 2%Aupre/Ti3AlxC2Ty and was 76.9% over 2%Audp/Ti3AlxC2Ty. The HMFCA (5-hydroxymethyl-2-furan carboxylic acid) selectivity over these two catalysts was almost identical, whereas it was 96.3% over 1%Aupre/Ti3AlxC2Ty and 84.3% over 1%Audp/Ti3AlxC2Ty. The catalyst reusability tests proved that the typical catalyst Aupre/Ti3AlxC2Ty maintained reaction rates and product selectivity in at least three cycles, whereas the reusability of Audp/Ti3AlxC2Ty catalyst was relatively weaker in both reactions. Finally, the plausible catalytic mechanism was discussed according to peer studies and the research results.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: